PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsretinitis pigmentosa
MeSH D012174 - retinitis pigmentosa
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015785:Hereditary eye diseases
0 Companies
0 Drugs
Success rate
D058499:Retinal dystrophies
0 Companies
0 Drugs
Success rate
D012174: 
Retinitis pigmentosa
1 Company
1 Drug
$
Success rate
D020788:Bardet-biedl syndrome
0 Companies
0 Drugs
Success rate
D056769:Alstrom syndrome
0 Companies
0 Drugs
Success rate
D052245:Usher syndromes
0 Companies
0 Drugs
Success rate
D007625:Kearns-sayre syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
0%
0/15
Phase 3
20%
1/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Voretigene neparvovec,
Bevifimod
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use